Companies: 10,795·Total market cap: $144.5T
CalciMedica, Inc.

CalciMedica, Inc.

CALCNASDAQHealthcare● Active
$0.96
$-0.10(-9.62%)
Market Cap$15134514
P/E Ratio
52W High$7.2
52W Low$0.461

CalciMedica, Inc.(CALC)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

calc · 股价预测 · 3 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 3 位华尔街分析师

SellBuy

Buy

3 位分析师

共识

评级分布

Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
合计: 3 · 买入占比: 66.7%

12 个月目标价

High

$392

Consensus

$266

+27666.2% upside

Low

$14.00

Median: $392 · Last Close: $0.96

CalciMedica, Inc.(CALC)的分析师共识为 Buy,基于过去 3 个月内 3 位华尔街分析师的评级。CALC 的 12 个月平均目标价为 $266.00,相对当前价 $0.96 代表 +27666.2% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

Bull

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$1.015.00%

1-day model range: $0.99–$1.02. Peak: $1.02 (+5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

64%29%7%
9Buy
4Neutral
1Sell
RSI (14)71.2Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · CALC · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.90BUY
MA 10$0.86BUY
MA 20$0.75BUY
MA 50$0.66BUY
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $CALC · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.92BUY
EMA 10$0.86BUY
EMA 20$0.78BUY
EMA 50$0.71BUY
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $CALC · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Oppenheimer2026-03-05
Maintains
OutperformOutperform
HC Wainwright & Co.2026-01-29
Downgrade ↓
BuyNeutral
HC Wainwright & Co.2025-05-15
Maintains
BuyBuy
HC Wainwright & Co.2025-04-01
Maintains
BuyBuy
HC Wainwright & Co.2025-03-04
Maintains
BuyBuy
HC Wainwright & Co.2024-11-14
Maintains
BuyBuy
HC Wainwright & Co.2024-11-04
Maintains
BuyBuy
HC Wainwright & Co.2024-08-13
Maintains
BuyBuy
Oppenheimer2024-07-10
Maintains
OutperformOutperform
HC Wainwright & Co.2024-07-09
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on CalciMedica, Inc. (CALC) stock. Of the recent 18 rating actions, 0 were upgrades and 1 were downgrades. 3 analysts currently cover CALC.

分析师推荐趋势

Buy ratings211
Hold ratings00
Sell ratings00

CALC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$2M

↓ 30.5% YoY

Revenue Next Year

$7M

↑ 174.0% YoY

EPS This Year

$-0.63

EPS Next Year

$-1.96

↑ 212.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CALC EPS of $-0.63 for the current fiscal year, based on estimates from 2 analysts. The CALC revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CALC 股价预测由两类独立数据源支撑:来自 3 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。CALC 的共识目标价为 $266.00(+27666.2% 上行空间),分析师共识为 Buy。

CALC 的短期预测(明日)为 $1.01(+5.00%)。

CalciMedica, Inc. 在 NASDAQ 上市,代码 CALC。CALC 在 2027 年的整体展望偏积极,在覆盖分析师中约 67% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

CALC 预测 · 8 个问题

根据 3 位华尔街分析师,CALC 的 12 个月平均目标价为 $266.00,最高 $392.00、最低 $14.00。若有图表,中位目标价可在上方查看。相对当前价 $0.96,隐含约 +27666.2% 的上行空间。

CALC 目标价CALC 分析师目标价CALC 12个月目标价目标价 CALC

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.